Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.144 Million Tokens, and Total Crypto and Total Cash Holdings of $14.2 Billion
January 5, 2026
Client News
-
-
Bitmine Immersion (BMNR) Announces ETH Holdings Reach 4.11 Million Tokens, and Total Crypto and Total Cash Holdings of $13.2 Billion
December 29, 2025
-
BitMine Immersion (BMNR) Announces ETH Holdings Exceeding 3.31 Million Tokens and Total Crypto and Cash Holdings of $14.2 Billion
October 27, 2025
-
BitMine Immersion (BMNR) Announces ETH Holdings Exceeding 2.83 Million Tokens and Total Crypto and Cash Holdings of $13.4 Billion
October 6, 2025
-
ONAR Holding Corporation Closes Acquisition of Retina AI; Follows Rapid Closing of JUICE to Accelerate AI-Driven Growth
September 23, 2025
-
SOLOWIN Expands Virtual Asset Services with Key License and Reports Significant Transactional Volume Growth
August 11, 2025
-
Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy
August 6, 2025
-
BitMine Immersion (BMNR) ETH Holdings Exceed 833,000 Tokens, Valued in Excess of $2.9 Billion, and Largest ETH Treasury in World
August 4, 2025
-
ONAR and IQSTEL Partner to Launch AI-Powered Multi-Agent System Redefining Agency Operations
July 29, 2025
-
La Rosa Holdings Corp. Extinguishes Majority of Outstanding Warrants Through Exchange Agreements, Strengthening Balance Sheet
July 24, 2025
-
Petvivo Holdings, Inc. and PiezoBioMembrane Inc. Announce Master Services Agreement to Jointly Develop Innovative Functional Biomaterials
May 22, 2025
-
Freight Technologies Announces 1-for-4 Reverse Share Split
May 22, 2025
-
Quipt Home Medical Confirms Receipt of Unsolicited Acquisition Proposal
May 21, 2025
-
The VF 8 Reflects a Shift Toward No-Compromise Electric Vehicles
May 21, 2025
-
La Rosa Holdings Corp. Reports Strong Q1 2025 Growth at Celebration, FL and BF Prime, Puerto Rico Offices Driven by Increased Agent Count, Revenue, and Transactions
May 7, 2025
-
OS Therapies Announces Issuance of U.S. Patent #12,239,738 Protecting Commercial Manufacturing Market Exclusivity for OST-HER2 in Rare Pediatric Cancer Osteosarcoma and Full Listeria Cancer Immunotherapy Platform into 2040
May 7, 2025